We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

1.
FIGURE 2.

FIGURE 2. From: Effect of soy isoflavone supplementation on nitric oxide metabolism and blood pressure in menopausal women1234.

Natural logarithmic transformation of blood isoflavone concentrations in the placebo group and the soy isoflavone–supplemented group at the end of the 6-wk study period. The asterisks above the columns denote significant differences (P < 0.01) between the 2 groups. The error bar above each column represents SD.

William W Wong, et al. Am J Clin Nutr. 2012 June;95(6):1487-1494.
2.
FIGURE 1.

FIGURE 1. From: Effect of soy isoflavone supplementation on nitric oxide metabolism and blood pressure in menopausal women1234.

Schematic diagram of the study design. At screening 1, informed consent was obtained from all potential study subjects followed by blood pressure and heart rate measurements. A fasting blood sample was collected for clinical blood chemistry, thyroid function, and follicle-stimulating hormone and isoflavone concentrations. At screening 2, study subjects who met the study inclusion criteria returned 1 wk later for a physical examination, dietary guidance to avoid foods high in nitrates, and blood pressure and heart rate measurements. The 2-d hemodynamic evaluation and stable-isotope infusion study were done on each subject at baseline and at the end of the 6-wk treatment period. The subjects were randomly assigned after the baseline assessments. All subjects continued to consume the placebo or isoflavone tablets until all posttreatment assessments had been done. Another fasting blood sample was collected at the end of the 6-wk treatment period to assess compliance.

William W Wong, et al. Am J Clin Nutr. 2012 June;95(6):1487-1494.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk